APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mental Disorders Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Mental Disorders Drugs Market Analysis and Forecast 2026-2032

27 December 2025190 pages

Choose your research edition.

Industry ResearchMental Disorders Drugs Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Mental Disorders Drugs Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Mental Disorders Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mental Disorders Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Mental Disorders Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Mental Disorders Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Mental Disorders Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Mental Disorders Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Mental Disorders Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Mental Disorders Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Mental Disorders Drugs include Johnson & Johnson, Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb and Abbott Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Mental Disorders Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Mental Disorders Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Mental Disorders Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Mental Disorders Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Mental Disorders Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Mental Disorders Drugs sales, projected growth trends, production technology, application and end-user industry.

Mental Disorders Drugs Segment by Company

Johnson & Johnson

Eli Lilly

Pfizer

GlaxoSmithKline

AstraZeneca

Bristol-Myers Squibb

Abbott Laboratories

Mental Disorders Drugs Segment by Type

Drugs for Childhood and Adolescent Mental Illness

Drugs for Schizophrenia

Anxiolytics

Antipsychotics

Antidepressants

Sleep Disorders

Drugs to Treat Cognitive Disorders

Drugs for the Treatment of Substance and Alcohol Addiction

Others

Mental Disorders Drugs Segment by Application

Adolescents

Children

Adults

Mental Disorders Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mental Disorders Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mental Disorders Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mental Disorders Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Mental Disorders Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Mental Disorders Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mental Disorders Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Mental Disorders Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Drugs for Childhood and Adolescent Mental Illness Major Manufacturers Table 3. Drugs for Schizophrenia Major Manufacturers Table 4. Anxiolytics Major Manufacturers Table 5. Antipsychotics Major Manufacturers Table 6. Antidepressants Major Manufacturers Table 7. Sleep Disorders Major Manufacturers Table 8. Drugs to Treat Cognitive Disorders Major Manufacturers Table 9. Drugs for the Treatment of Substance and Alcohol Addiction Major Manufacturers Table 10. Others Major Manufacturers Table 11. Global Mental Disorders Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 12. Adolescents Major Manufacturers Table 13. Children Major Manufacturers Table 14. Adults Major Manufacturers Table 15. Mental Disorders Drugs Industry Trends Table 16. Mental Disorders Drugs Industry Drivers Table 17. Mental Disorders Drugs Industry Opportunities and Challenges Table 18. Mental Disorders Drugs Industry Restraints Table 19. Global Mental Disorders Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Mental Disorders Drugs Revenue by Region (2021-2026) & (US$ Million) Table 21. Global Mental Disorders Drugs Revenue by Region (2027-2032) & (US$ Million) Table 22. Global Mental Disorders Drugs Revenue Market Share by Region (2021-2026) Table 23. Global Mental Disorders Drugs Revenue Market Share by Region (2027-2032) Table 24. Global Mental Disorders Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 25. Global Mental Disorders Drugs Sales by Region (2021-2026) & (W Units) Table 26. Global Mental Disorders Drugs Sales by Region (2027-2032) & (W Units) Table 27. Global Mental Disorders Drugs Sales Market Share by Region (2021-2026) Table 28. Global Mental Disorders Drugs Sales Market Share by Region (2027-2032) Table 29. Global Mental Disorders Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Mental Disorders Drugs Revenue Market Share by Manufacturers (2021-2026) Table 31. Global Mental Disorders Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 32. Global Mental Disorders Drugs Sales Market Share by Manufacturers (2021-2026) Table 33. Global Mental Disorders Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 34. Global Mental Disorders Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 35. Global Mental Disorders Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 36. Global Mental Disorders Drugs Manufacturers, Product Type & Application Table 37. Global Mental Disorders Drugs Manufacturers' Establishment Date Table 38. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 39. Global Mental Disorders Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Mental Disorders Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Mental Disorders Drugs Revenue by Type (2021-2026) & (US$ Million) Table 42. Global Mental Disorders Drugs Revenue by Type (2027-2032) & (US$ Million) Table 43. Global Mental Disorders Drugs Revenue Market Share by Type (2021-2026) Table 44. Global Mental Disorders Drugs Revenue Market Share by Type (2027-2032) Table 45. Global Mental Disorders Drugs Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 46. Global Mental Disorders Drugs Sales by Type (2021-2026) & (W Units) Table 47. Global Mental Disorders Drugs Sales by Type (2027-2032) & (W Units) Table 48. Global Mental Disorders Drugs Sales Market Share by Type (2021-2026) Table 49. Global Mental Disorders Drugs Sales Market Share by Type (2027-2032) Table 50. Global Mental Disorders Drugs Price by Type (2021-2026) & (US$/Unit) Table 51. Global Mental Disorders Drugs Price by Type (2027-2032) & (US$/Unit) Table 52. Global Mental Disorders Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Mental Disorders Drugs Revenue by Application (2021-2026) & (US$ Million) Table 54. Global Mental Disorders Drugs Revenue by Application (2027-2032) & (US$ Million) Table 55. Global Mental Disorders Drugs Revenue Market Share by Application (2021-2026) Table 56. Global Mental Disorders Drugs Revenue Market Share by Application (2027-2032) Table 57. Global Mental Disorders Drugs Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 58. Global Mental Disorders Drugs Sales by Application (2021-2026) & (W Units) Table 59. Global Mental Disorders Drugs Sales by Application (2027-2032) & (W Units) Table 60. Global Mental Disorders Drugs Sales Market Share by Application (2021-2026) Table 61. Global Mental Disorders Drugs Sales Market Share by Application (2027-2032) Table 62. Global Mental Disorders Drugs Price by Application (2021-2026) & (US$/Unit) Table 63. Global Mental Disorders Drugs Price by Application (2027-2032) & (US$/Unit) Table 64. Johnson & Johnson Company Information Table 65. Johnson & Johnson Business Overview Table 66. Johnson & Johnson Mental Disorders Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Johnson & Johnson Mental Disorders Drugs Product Portfolio Table 68. Johnson & Johnson Recent Development Table 69. Eli Lilly Company Information Table 70. Eli Lilly Business Overview Table 71. Eli Lilly Mental Disorders Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Eli Lilly Mental Disorders Drugs Product Portfolio Table 73. Eli Lilly Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer Mental Disorders Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Pfizer Mental Disorders Drugs Product Portfolio Table 78. Pfizer Recent Development Table 79. GlaxoSmithKline Company Information Table 80. GlaxoSmithKline Business Overview Table 81. GlaxoSmithKline Mental Disorders Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. GlaxoSmithKline Mental Disorders Drugs Product Portfolio Table 83. GlaxoSmithKline Recent Development Table 84. AstraZeneca Company Information Table 85. AstraZeneca Business Overview Table 86. AstraZeneca Mental Disorders Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. AstraZeneca Mental Disorders Drugs Product Portfolio Table 88. AstraZeneca Recent Development Table 89. Bristol-Myers Squibb Company Information Table 90. Bristol-Myers Squibb Business Overview Table 91. Bristol-Myers Squibb Mental Disorders Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Bristol-Myers Squibb Mental Disorders Drugs Product Portfolio Table 93. Bristol-Myers Squibb Recent Development Table 94. Abbott Laboratories Company Information Table 95. Abbott Laboratories Business Overview Table 96. Abbott Laboratories Mental Disorders Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Abbott Laboratories Mental Disorders Drugs Product Portfolio Table 98. Abbott Laboratories Recent Development Table 99. North America Mental Disorders Drugs Revenue by Type (2021-2026) & (US$ Million) Table 100. North America Mental Disorders Drugs Revenue by Type (2027-2032) & (US$ Million) Table 101. North America Mental Disorders Drugs Sales by Type (2021-2026) & (W Units) Table 102. North America Mental Disorders Drugs Sales by Type (2027-2032) & (W Units) Table 103. North America Mental Disorders Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 104. North America Mental Disorders Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 105. North America Mental Disorders Drugs Revenue by Application (2021-2026) & (US$ Million) Table 106. North America Mental Disorders Drugs Revenue by Application (2027-2032) & (US$ Million) Table 107. North America Mental Disorders Drugs Sales by Application (2021-2026) & (W Units) Table 108. North America Mental Disorders Drugs Sales by Application (2027-2032) & (W Units) Table 109. North America Mental Disorders Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 110. North America Mental Disorders Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 111. North America Mental Disorders Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Mental Disorders Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 113. North America Mental Disorders Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 114. North America Mental Disorders Drugs Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 115. North America Mental Disorders Drugs Sales by Country (2021-2026) & (W Units) Table 116. North America Mental Disorders Drugs Sales by Country (2027-2032) & (W Units) Table 117. North America Mental Disorders Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 118. North America Mental Disorders Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 119. United States Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 120. Canada Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 121. Mexico Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 122. Europe Mental Disorders Drugs Revenue by Type (2021-2026) & (US$ Million) Table 123. Europe Mental Disorders Drugs Revenue by Type (2027-2032) & (US$ Million) Table 124. Europe Mental Disorders Drugs Sales by Type (2021-2026) & (W Units) Table 125. Europe Mental Disorders Drugs Sales by Type (2027-2032) & (W Units) Table 126. Europe Mental Disorders Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 127. Europe Mental Disorders Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 128. Europe Mental Disorders Drugs Revenue by Application (2021-2026) & (US$ Million) Table 129. Europe Mental Disorders Drugs Revenue by Application (2027-2032) & (US$ Million) Table 130. Europe Mental Disorders Drugs Sales by Application (2021-2026) & (W Units) Table 131. Europe Mental Disorders Drugs Sales by Application (2027-2032) & (W Units) Table 132. Europe Mental Disorders Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 133. Europe Mental Disorders Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 134. Europe Mental Disorders Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Europe Mental Disorders Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. Europe Mental Disorders Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. Europe Mental Disorders Drugs Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 138. Europe Mental Disorders Drugs Sales by Country (2021-2026) & (W Units) Table 139. Europe Mental Disorders Drugs Sales by Country (2027-2032) & (W Units) Table 140. Europe Mental Disorders Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 141. Europe Mental Disorders Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 142. Germany Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 143. France Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 144. U.K. Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 145. Italy Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 146. Russia Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 147. Spain Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 148. Netherlands Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 149. Switzerland Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 150. Sweden Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 151. Poland Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 152. China Mental Disorders Drugs Revenue by Type (2021-2026) & (US$ Million) Table 153. China Mental Disorders Drugs Revenue by Type (2027-2032) & (US$ Million) Table 154. China Mental Disorders Drugs Sales by Type (2021-2026) & (W Units) Table 155. China Mental Disorders Drugs Sales by Type (2027-2032) & (W Units) Table 156. China Mental Disorders Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 157. China Mental Disorders Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 158. China Mental Disorders Drugs Revenue by Application (2021-2026) & (US$ Million) Table 159. China Mental Disorders Drugs Revenue by Application (2027-2032) & (US$ Million) Table 160. China Mental Disorders Drugs Sales by Application (2021-2026) & (W Units) Table 161. China Mental Disorders Drugs Sales by Application (2027-2032) & (W Units) Table 162. China Mental Disorders Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 163. China Mental Disorders Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 164. Asia Mental Disorders Drugs Revenue by Type (2021-2026) & (US$ Million) Table 165. Asia Mental Disorders Drugs Revenue by Type (2027-2032) & (US$ Million) Table 166. Asia Mental Disorders Drugs Sales by Type (2021-2026) & (W Units) Table 167. Asia Mental Disorders Drugs Sales by Type (2027-2032) & (W Units) Table 168. Asia Mental Disorders Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 169. Asia Mental Disorders Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 170. Asia Mental Disorders Drugs Revenue by Application (2021-2026) & (US$ Million) Table 171. Asia Mental Disorders Drugs Revenue by Application (2027-2032) & (US$ Million) Table 172. Asia Mental Disorders Drugs Sales by Application (2021-2026) & (W Units) Table 173. Asia Mental Disorders Drugs Sales by Application (2027-2032) & (W Units) Table 174. Asia Mental Disorders Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 175. Asia Mental Disorders Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 176. Asia Mental Disorders Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Asia Mental Disorders Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. Asia Mental Disorders Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. Asia Mental Disorders Drugs Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 180. Asia Mental Disorders Drugs Sales by Country (2021-2026) & (W Units) Table 181. Asia Mental Disorders Drugs Sales by Country (2027-2032) & (W Units) Table 182. Asia Mental Disorders Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 183. Asia Mental Disorders Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 184. Japan Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 185. South Korea Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 186. India Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 187. Australia Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 188. Taiwan Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 189. Southeast Asia Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 190. SAMEA Mental Disorders Drugs Revenue by Type (2021-2026) & (US$ Million) Table 191. SAMEA Mental Disorders Drugs Revenue by Type (2027-2032) & (US$ Million) Table 192. SAMEA Mental Disorders Drugs Sales by Type (2021-2026) & (W Units) Table 193. SAMEA Mental Disorders Drugs Sales by Type (2027-2032) & (W Units) Table 194. SAMEA Mental Disorders Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 195. SAMEA Mental Disorders Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 196. SAMEA Mental Disorders Drugs Revenue by Application (2021-2026) & (US$ Million) Table 197. SAMEA Mental Disorders Drugs Revenue by Application (2027-2032) & (US$ Million) Table 198. SAMEA Mental Disorders Drugs Sales by Application (2021-2026) & (W Units) Table 199. SAMEA Mental Disorders Drugs Sales by Application (2027-2032) & (W Units) Table 200. SAMEA Mental Disorders Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 201. SAMEA Mental Disorders Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 202. SAMEA Mental Disorders Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. SAMEA Mental Disorders Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. SAMEA Mental Disorders Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. SAMEA Mental Disorders Drugs Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 206. SAMEA Mental Disorders Drugs Sales by Country (2021-2026) & (W Units) Table 207. SAMEA Mental Disorders Drugs Sales by Country (2027-2032) & (W Units) Table 208. SAMEA Mental Disorders Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 209. SAMEA Mental Disorders Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 210. Brazil Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 211. Argentina Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 212. Chile Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 213. Colombia Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 214. Peru Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 215. Saudi Arabia Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 216. Israel Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 217. UAE Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 218. Turkey Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 219. Iran Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 220. Egypt Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Mental Disorders Drugs Distributors List Table 224. Mental Disorders Drugs Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Mental Disorders Drugs Image Figure 2. Global Mental Disorders Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mental Disorders Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Drugs for Childhood and Adolescent Mental Illness Image Figure 5. Drugs for Schizophrenia Image Figure 6. Anxiolytics Image Figure 7. Antipsychotics Image Figure 8. Antidepressants Image Figure 9. Sleep Disorders Image Figure 10. Drugs to Treat Cognitive Disorders Image Figure 11. Drugs for the Treatment of Substance and Alcohol Addiction Image Figure 12. Others Image Figure 13. Global Mental Disorders Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Mental Disorders Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 15. Adolescents Image Figure 16. Children Image Figure 17. Adults Image Figure 18. Global Mental Disorders Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Mental Disorders Drugs Revenue (2021-2032) & (US$ Million) Figure 20. Global Mental Disorders Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Mental Disorders Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 22. Global Mental Disorders Drugs Revenue Market Share by Region (2021-2032) Figure 23. Global Mental Disorders Drugs Sales (2021-2032) & (W Units) Figure 24. Global Mental Disorders Drugs Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 25. Global Mental Disorders Drugs Sales Market Share by Region (2021-2032) Figure 26. US & Canada & Mexico Mental Disorders Drugs Sales YoY (2021-2032) & (W Units) Figure 27. Europe Mental Disorders Drugs Sales YoY (2021-2032) & (W Units) Figure 28. China Mental Disorders Drugs Sales YoY (2021-2032) & (W Units) Figure 29. Asia (Excluding China) Mental Disorders Drugs Sales YoY (2021-2032) & (W Units) Figure 30. South America, Middle East and Africa Mental Disorders Drugs Sales YoY (2021-2032) & (W Units) Figure 31. Global Mental Disorders Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 32. Global Mental Disorders Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 33. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 34. Global Mental Disorders Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Mental Disorders Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Mental Disorders Drugs Revenue Market Share by Type (2021-2032) Figure 37. Global Mental Disorders Drugs Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 38. Global Mental Disorders Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 39. Global Mental Disorders Drugs Sales Market Share by Type (2021-2032) Figure 40. Global Mental Disorders Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 41. Global Mental Disorders Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Mental Disorders Drugs Revenue Market Share by Application (2021-2032) Figure 43. Global Mental Disorders Drugs Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 44. Global Mental Disorders Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 45. Global Mental Disorders Drugs Sales Market Share by Application (2021-2032) Figure 46. North America Mental Disorders Drugs Revenue Share by Type (2021-2032) Figure 47. North America Mental Disorders Drugs Sales Share by Type (2021-2032) Figure 48. North America Mental Disorders Drugs Revenue Share by Application (2021-2032) Figure 49. North America Mental Disorders Drugs Sales Share by Application (2021-2032) Figure 50. North America Mental Disorders Drugs Revenue Share by Country (2021-2032) Figure 51. North America Mental Disorders Drugs Sales Share by Country (2021-2032) Figure 52. Europe Mental Disorders Drugs Revenue Share by Type (2021-2032) Figure 53. Europe Mental Disorders Drugs Sales Share by Type (2021-2032) Figure 54. Europe Mental Disorders Drugs Revenue Share by Application (2021-2032) Figure 55. Europe Mental Disorders Drugs Sales Share by Application (2021-2032) Figure 56. Europe Mental Disorders Drugs Revenue Share by Country (2021-2032) Figure 57. Europe Mental Disorders Drugs Sales Share by Country (2021-2032) Figure 58. China Mental Disorders Drugs Revenue Share by Type (2021-2032) Figure 59. China Mental Disorders Drugs Sales Share by Type (2021-2032) Figure 60. China Mental Disorders Drugs Revenue Share by Application (2021-2032) Figure 61. China Mental Disorders Drugs Sales Share by Application (2021-2032) Figure 62. Asia Mental Disorders Drugs Revenue Share by Type (2021-2032) Figure 63. Asia Mental Disorders Drugs Sales Share by Type (2021-2032) Figure 64. Asia Mental Disorders Drugs Revenue Share by Application (2021-2032) Figure 65. Asia Mental Disorders Drugs Sales Share by Application (2021-2032) Figure 66. Asia Mental Disorders Drugs Revenue Share by Country (2021-2032) Figure 67. Asia Mental Disorders Drugs Sales Share by Country (2021-2032) Figure 68. SAMEA Mental Disorders Drugs Revenue Share by Type (2021-2032) Figure 69. SAMEA Mental Disorders Drugs Sales Share by Type (2021-2032) Figure 70. SAMEA Mental Disorders Drugs Revenue Share by Application (2021-2032) Figure 71. SAMEA Mental Disorders Drugs Sales Share by Application (2021-2032) Figure 72. SAMEA Mental Disorders Drugs Revenue Share by Country (2021-2032) Figure 73. SAMEA Mental Disorders Drugs Sales Share by Country (2021-2032) Figure 74. Mental Disorders Drugs Value Chain Figure 75. Manufacturing Cost Structure Figure 76. Mental Disorders Drugs Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Drugs for Childhood and Adolescent Mental Illness
  • Drugs for Schizophrenia
  • Anxiolytics
  • Antipsychotics
  • Antidepressants
  • Sleep Disorders
  • Drugs to Treat Cognitive Disorders
  • Drugs for the Treatment of Substance and Alcohol Addiction
  • Others
Applications
  • Adolescents
  • Children
  • Adults
Companies covered
  • Johnson & Johnson
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Bristol-Myers Squibb
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Mental Disorders Drugs Market by Type
  3. 1.2.1 Global Mental Disorders Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Drugs for Childhood and Adolescent Mental Illness
  5. 1.2.3 Drugs for Schizophrenia
  6. 1.2.4 Anxiolytics
  7. 1.2.5 Antipsychotics
  8. 1.2.6 Antidepressants
  9. 1.2.7 Sleep Disorders
  10. 1.2.8 Drugs to Treat Cognitive Disorders
  11. 1.2.9 Drugs for the Treatment of Substance and Alcohol Addiction
  12. 1.2.10 Others
  13. 1.3 Mental Disorders Drugs Market by Application
  14. 1.3.1 Global Mental Disorders Drugs Market Size by Application, 2021 VS 2025 VS 2032
  15. 1.3.2 Adolescents
  16. 1.3.3 Children
  17. 1.3.4 Adults
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 Mental Disorders Drugs Market Dynamics
  1. 2.1 Mental Disorders Drugs Industry Trends
  2. 2.2 Mental Disorders Drugs Industry Drivers
  3. 2.3 Mental Disorders Drugs Industry Opportunities and Challenges
  4. 2.4 Mental Disorders Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Mental Disorders Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Mental Disorders Drugs Revenue by Region
  3. 3.2.1 Global Mental Disorders Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Mental Disorders Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Mental Disorders Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Mental Disorders Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Mental Disorders Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Mental Disorders Drugs Sales by Region
  9. 3.4.1 Global Mental Disorders Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Mental Disorders Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Mental Disorders Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Mental Disorders Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Mental Disorders Drugs Revenue by Manufacturers
  2. 4.1.1 Global Mental Disorders Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Mental Disorders Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Mental Disorders Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Mental Disorders Drugs Sales by Manufacturers
  6. 4.2.1 Global Mental Disorders Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Mental Disorders Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Mental Disorders Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Mental Disorders Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Mental Disorders Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Mental Disorders Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Mental Disorders Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Mental Disorders Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Mental Disorders Drugs Market CR5 and HHI
  16. 4.8.2 2025 Mental Disorders Drugs Tier 1, Tier 2, and Tier 3
5 Mental Disorders Drugs Market by Type
  1. 5.1 Global Mental Disorders Drugs Revenue by Type
  2. 5.1.1 Global Mental Disorders Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Mental Disorders Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Mental Disorders Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Mental Disorders Drugs Sales by Type
  6. 5.2.1 Global Mental Disorders Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mental Disorders Drugs Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Mental Disorders Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Mental Disorders Drugs Price by Type
6 Mental Disorders Drugs Market by Application
  1. 6.1 Global Mental Disorders Drugs Revenue by Application
  2. 6.1.1 Global Mental Disorders Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Mental Disorders Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Mental Disorders Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Mental Disorders Drugs Sales by Application
  6. 6.2.1 Global Mental Disorders Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Mental Disorders Drugs Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Mental Disorders Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Mental Disorders Drugs Price by Application
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson Mental Disorders Drugs Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Eli Lilly
  8. 7.2.1 Eli Lilly Company Information
  9. 7.2.2 Eli Lilly Business Overview
  10. 7.2.3 Eli Lilly Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eli Lilly Mental Disorders Drugs Product Portfolio
  12. 7.2.5 Eli Lilly Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Mental Disorders Drugs Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 GlaxoSmithKline
  20. 7.4.1 GlaxoSmithKline Company Information
  21. 7.4.2 GlaxoSmithKline Business Overview
  22. 7.4.3 GlaxoSmithKline Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GlaxoSmithKline Mental Disorders Drugs Product Portfolio
  24. 7.4.5 GlaxoSmithKline Recent Developments
  25. 7.5 AstraZeneca
  26. 7.5.1 AstraZeneca Company Information
  27. 7.5.2 AstraZeneca Business Overview
  28. 7.5.3 AstraZeneca Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 AstraZeneca Mental Disorders Drugs Product Portfolio
  30. 7.5.5 AstraZeneca Recent Developments
  31. 7.6 Bristol-Myers Squibb
  32. 7.6.1 Bristol-Myers Squibb Company Information
  33. 7.6.2 Bristol-Myers Squibb Business Overview
  34. 7.6.3 Bristol-Myers Squibb Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Bristol-Myers Squibb Mental Disorders Drugs Product Portfolio
  36. 7.6.5 Bristol-Myers Squibb Recent Developments
  37. 7.7 Abbott Laboratories
  38. 7.7.1 Abbott Laboratories Company Information
  39. 7.7.2 Abbott Laboratories Business Overview
  40. 7.7.3 Abbott Laboratories Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Abbott Laboratories Mental Disorders Drugs Product Portfolio
  42. 7.7.5 Abbott Laboratories Recent Developments
8 North America
  1. 8.1 North America Mental Disorders Drugs Market Size by Type
  2. 8.1.1 North America Mental Disorders Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Mental Disorders Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Mental Disorders Drugs Price by Type (2021-2032)
  5. 8.2 North America Mental Disorders Drugs Market Size by Application
  6. 8.2.1 North America Mental Disorders Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Mental Disorders Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Mental Disorders Drugs Price by Application (2021-2032)
  9. 8.3 North America Mental Disorders Drugs Market Size by Country
  10. 8.3.1 North America Mental Disorders Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Mental Disorders Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Mental Disorders Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Mental Disorders Drugs Market Size by Type
  2. 9.1.1 Europe Mental Disorders Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Mental Disorders Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Mental Disorders Drugs Price by Type (2021-2032)
  5. 9.2 Europe Mental Disorders Drugs Market Size by Application
  6. 9.2.1 Europe Mental Disorders Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Mental Disorders Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Mental Disorders Drugs Price by Application (2021-2032)
  9. 9.3 Europe Mental Disorders Drugs Market Size by Country
  10. 9.3.1 Europe Mental Disorders Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Mental Disorders Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Mental Disorders Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Mental Disorders Drugs Market Size by Type
  2. 10.1.1 China Mental Disorders Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Mental Disorders Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Mental Disorders Drugs Price by Type (2021-2032)
  5. 10.2 China Mental Disorders Drugs Market Size by Application
  6. 10.2.1 China Mental Disorders Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Mental Disorders Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Mental Disorders Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Mental Disorders Drugs Market Size by Type
  2. 11.1.1 Asia Mental Disorders Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Mental Disorders Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Mental Disorders Drugs Price by Type (2021-2032)
  5. 11.2 Asia Mental Disorders Drugs Market Size by Application
  6. 11.2.1 Asia Mental Disorders Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Mental Disorders Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Mental Disorders Drugs Price by Application (2021-2032)
  9. 11.3 Asia Mental Disorders Drugs Market Size by Country
  10. 11.3.1 Asia Mental Disorders Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Mental Disorders Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Mental Disorders Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Mental Disorders Drugs Market Size by Type
  2. 12.1.1 SAMEA Mental Disorders Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Mental Disorders Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Mental Disorders Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Mental Disorders Drugs Market Size by Application
  6. 12.2.1 SAMEA Mental Disorders Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Mental Disorders Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Mental Disorders Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Mental Disorders Drugs Market Size by Country
  10. 12.3.1 SAMEA Mental Disorders Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Mental Disorders Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Mental Disorders Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Mental Disorders Drugs Value Chain Analysis
  2. 13.1.1 Mental Disorders Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Mental Disorders Drugs Production Mode & Process
  6. 13.2 Mental Disorders Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Mental Disorders Drugs Distributors
  9. 13.2.3 Mental Disorders Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst